158 related articles for article (PubMed ID: 22749861)
1. Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome.
Kaida Y; Ueda S; Yamagishi S; Nakayama Y; Ando R; Iwatani R; Fukami K; Okuda S
Life Sci; 2012 Sep; 91(9-10):301-5. PubMed ID: 22749861
[TBL] [Abstract][Full Text] [Related]
2. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
Chen Y; Xu X; Sheng M; Zhang X; Gu Q; Zheng Z
Exp Eye Res; 2009 Dec; 89(6):1028-34. PubMed ID: 19748504
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ
Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
[TBL] [Abstract][Full Text] [Related]
6. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
Matsumoto Y; Ueda S; Yamagishi S; Matsuguma K; Shibata R; Fukami K; Matsuoka H; Imaizumi T; Okuda S
J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
[TBL] [Abstract][Full Text] [Related]
7. Effects of losartan and pentoxifylline on renal dimethylarginine dimethylaminohydrolase-1 expression in proteinuric nephropathy.
Park SH; Hyun SH; Ryu HM; Ahn JS; Oh SH; Oh EJ; Yoon SH; Choi JY; Cho JH; Kim CD; Kim YL
Am J Nephrol; 2013; 37(5):491-500. PubMed ID: 23635662
[TBL] [Abstract][Full Text] [Related]
8. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
[TBL] [Abstract][Full Text] [Related]
9. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase.
Scalera F; Kielstein JT; Martens-Lobenhoffer J; Postel SC; Täger M; Bode-Böger SM
J Am Soc Nephrol; 2005 Apr; 16(4):892-8. PubMed ID: 15728783
[TBL] [Abstract][Full Text] [Related]
11. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
[TBL] [Abstract][Full Text] [Related]
12. Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.
Sasser JM; Cunningham MW; Baylis C
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1355-62. PubMed ID: 25298524
[TBL] [Abstract][Full Text] [Related]
13. The ADMA/DDAH/NO pathway in human vein endothelial cells exposed to arsenite.
Osorio-Yáñez C; Chin-Chan M; Sánchez-Peña LC; Atzatzi-Aguilar OG; Olivares-Reyes JA; Segovia J; Del Razo LM
Toxicol In Vitro; 2017 Aug; 42():281-286. PubMed ID: 28502835
[TBL] [Abstract][Full Text] [Related]
14. Dimethylarginine Dimethylaminohydrolase 1 Deficiency Induces the Epithelial to Mesenchymal Transition in Renal Proximal Tubular Epithelial Cells and Exacerbates Kidney Damage in Aged and Diabetic Mice.
Shi L; Zhao C; Wang H; Lei T; Liu S; Cao J; Lu Z
Antioxid Redox Signal; 2017 Dec; 27(16):1347-1360. PubMed ID: 28594240
[TBL] [Abstract][Full Text] [Related]
15. Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction.
Ando R; Ueda S; Yamagishi S; Miyazaki H; Kaida Y; Kaifu K; Yokoro M; Nakayama Y; Obara N; Fukami K; Takeuchi M; Okuda S
Diab Vasc Dis Res; 2013 Sep; 10(5):436-41. PubMed ID: 23766377
[TBL] [Abstract][Full Text] [Related]
16. Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells.
Osanai T; Saitoh M; Sasaki S; Tomita H; Matsunaga T; Okumura K
Hypertension; 2003 Nov; 42(5):985-90. PubMed ID: 14557285
[TBL] [Abstract][Full Text] [Related]
17. Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys.
Wu M; Lin P; Li L; Chen D; Yang X; Xu L; Zhou B; Wang C; Zhang Y; Luo C; Ye C
FASEB J; 2019 Jun; 33(6):6948-6956. PubMed ID: 30840839
[TBL] [Abstract][Full Text] [Related]
18. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
Onozato ML; Tojo A; Leiper J; Fujita T; Palm F; Wilcox CS
Diabetes; 2008 Jan; 57(1):172-80. PubMed ID: 17909098
[TBL] [Abstract][Full Text] [Related]
19. Icariin regulates PRMT/ADMA/DDAH pathway to improve endothelial function.
Xiao HB; Liu ZK; Lu XY; Deng CN; Luo ZF
Pharmacol Rep; 2015 Dec; 67(6):1147-54. PubMed ID: 26481534
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylarginine exacerbates Aβ-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.
Luo Y; Yue W; Quan X; Wang Y; Zhao B; Lu Z
Free Radic Biol Med; 2015 Feb; 79():117-26. PubMed ID: 25499850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
